MedTrace Logo

Antibiotics During Intrauterine Balloon Tamponade Placement

NCT03478163 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2021-10-07

Study results available
· View outcomes & findings →

Summary

The goal of this study is to identify whether antibiotics given at the time of placement of an intrauterine balloon tamponade (IBT) will result in reduction of the risk of endometritis. The investigators hypothesize that antibiotics given at the time of intrauterine balloon tamponade will reduce the likelihood of postpartum endometritis.

Conditions

  • Obstetric Complication
  • Postpartum Hemorrhage
  • Postpartum Endometritis

Interventions

DRUG

CeFAZolin 1000 MG

Cefazolin 1000 mg every 8 hours for 3 doses

DRUG

Clindamycin 900 MG in 6 ML Injection

Clindamycin 900 mg every 8 hours for 3 doses

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Kimberly Gregory, MD MPH · Cedars-Sinai Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-08
Primary Completion
2021-05-03
Completion
2021-05-03
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03478163 on ClinicalTrials.gov